Perficient: Drug Development

FEBRUARY 12, 2025

This transformation will require a delicate balance between innovation and compliance, ensuring that advancements in AI contribute to a secure and efficient payments landscape. These changes require significant adjustments in risk management, compliance frameworks, and operational protocols.

Compliance 52

Compliance Regulations Production Government 52

Perficient: Drug Development

SEPTEMBER 6, 2024

What Makes Salesforce a Leader in B2B E-Commerce: Key Takeaways from the Forrester Wave Q2 2024 Michael Affronti , Executive VP & GM of Commerce Cloud at Salesforce, recently expressed his excitement on LinkedIn about Salesforce being named a Leader in the Forrester Wave: Commerce Solutions for B2B, Q2 2024 report.

Marketing 59

Marketing Compliance Production Engineering 59

Alta Sciences

JULY 25, 2024

Top 10 Life Science Resources for Summer 2024 pmjackson Thu, 07/25/2024 - 14:44 There’s a lot of life science content out there, which is why we’ve curated a selection of our expert insights, tips, case studies, and scientific and regulatory information for your convenience. Catch up on what you might have missed below!

Science 52

Science Clinical Trials Clinical Pharmacology FDA 52

Drug Target Review

JULY 7, 2025

Non-human primates (NHPs), such as macaques and cynomolgus monkeys, have long served as a cornerstone in preclinical drug development due to their close genetic, anatomical and physiological resemblance to humans. Food and Drug Administration (FDA). Ncardia, 2024. Bailey J, et al. Experimental Biology and Medicine.

Drug Research 52

Drug Research Research Animal Testing Drugs 52

Perficient: Drug Development

JUNE 19, 2024

Our risk and regulatory compliance experts, Carl Aridas and Chandni Patel, have just returned from XLoD 2024 in New York. Conquer Compliance The insights that Carl and Chandni gathered at XLoD highlight the ongoing evolution within the industry.

Compliance 52

Compliance Regulations Production 52

Perficient: Drug Development

MAY 1, 2024

As of mid-February 2024, the Spring ‘24 release was generally available across all instances of Health Cloud bringing with it a host of improvements and added functionality for healthcare organizations. Additionally, optimized time-to-therapy enhancements and transportation logistic modeling enhance operational efficiency and compliance.

Compliance 59

Compliance Therapies Production 59

Perficient: Drug Development

SEPTEMBER 9, 2024

Here are the key takeaways and insights you should know coming into Dreamforce 2024: The Agentic AI Approach: Automation at Scale The crux of Agentforce lies in its ability to deploy multiple autonomous AI agents within an organization. Data Cloud: Fueling AI with High-Quality Data In any AI endeavor, data is the key to success.

Compliance 52

Compliance Marketing Production 52

Alta Sciences

NOVEMBER 15, 2024

4 Essential Topics to Cover in Your First CRO Meeting pmjackson Fri, 11/15/2024 - 19:22 Starting a partnership with a contract research organization (CRO) is a sometimes intimidating—yet exciting—first step in your drug development journey.

Drug Development 52

Drug Development Clinical Trials Trials Drugs 52

Perficient: Drug Development

NOVEMBER 19, 2024

On April 19, 2024, the Japanese government published new “AI Guidelines for Business Version 1.0” (the “Guidelines”). On May 22, 2024, the Council submitted draft discussion points concerning the advisability and potential scope of any future regulation.

Regulations 52

Regulations Government Compliance Marketing 52

Perficient: Drug Development

DECEMBER 27, 2024

Regulatory Compliance: Ensure compliance with regulatory requirements through automated monitoring and reporting. This assessment covers data quality, compliance, security, and language learning models (LLMs). Financial Services Risk Management: Use AI to detect fraud and manage risks more effectively. and Perficient.

Compliance 52

Compliance Production Treatment Marketing 52

Perficient: Drug Development

JANUARY 3, 2024

As we enter 2024, most of the conversations we have are focused on XM Cloud. HIPAA Compliance is Coming At Perficient, Healthcare is one of our biggest industry verticals. At the same time, front end hosting partners Vercel and Netlify have both indicated HIPAA compliance and BAA agreements should be supported early in 2024.

Compliance 52

Compliance Marketing Production Licensing 52

DS in Pharmatics

JUNE 12, 2024

Date: June 12, 2024 Location: San Diego, CA ProductLife Group (PLG), a leading provider of product development and compliance services in the pharmaceutical and biotechnological sectors, is excited to announce a comprehensive solution aimed at transforming the landscape of drug development, underscoring PLG's commitment to advancing healthcare through (..)

Production 52

Production Pharmaceuticals Compliance Drug Development 52

Drug Target Review

JUNE 5, 2025

Currently, three FDA-approved disease-modifying drug therapies are available: hydroxyurea, crizanlizumab and L-glutamine, though each has limitations that affect patient compliance. 2024 Sep 10;2:101875. Blood Adv (2024) 8 (4): 10181029. The therapeutic landscape for SCD has evolved significantly in recent years.

Disease 52

Disease Treatment Therapies Nurses 52

The Pharma Data

JUNE 6, 2025

billion in 2024 to $24.8 From providing KOL (Key Opinion Leader) engagement personnel to facilitating local regulatory compliance, CSOs serve as essential partners in ensuring the commercial success of pharmaceutical assets across varied healthcare environments. Equally important is regulatory compliance.

Pharmaceutical Companies 40

Pharmaceutical Companies Compliance Pharmaceuticals International 40

Perficient: Drug Development

FEBRUARY 15, 2024

The NYSDFS Part 500 amendments signal a crucial shift in the financial services regulatory landscape and underscore the importance of robust governance, risk management, and compliance frameworks. Impacted institutions are subject to significant fines relative to the level of non-compliance identified by the regulators.

Compliance 52

Compliance Regulations Licensing Licensing 52

Fierce BioTech

APRIL 4, 2024

Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Ensure regulatory compliance through efficient management of documentation, audits, and reporting, powered by AI automation. Listing Image Appian-LogoListing-9142023.png

Science 52

Science Compliance Drug Development Treatment 52

Fierce BioTech

JANUARY 12, 2024

Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.

Drugs 52

Drugs Packaging Compliance Drug Development 52

Perficient: Drug Development

FEBRUARY 15, 2024

These DFS500 amendments signal a crucial shift in the regulatory landscape, emphasizing the imperative for robust governance, risk management, and compliance frameworks across the financial industry. Impacted institutions are subject to significant fines relative to the level of non-compliance identified by the regulators.

Compliance 52

Compliance Licensing Licensing Regulations 52

Alta Sciences

JULY 18, 2024

Inside The Altascientist: How to Achieve Optimal Preclinical Formulation and Drug Product Manufacture aasimakopoulos Thu, 07/18/2024 - 20:33 Formulating and manufacturing drugs for preclinical testing is an early—and necessary—step towards pushing your molecule through to human clinical trials.

Production 52

Production Clinical Trials Drugs Compliance 52

Perficient: Drug Development

DECEMBER 27, 2023

YOU MAY ENJOY: Regulatory Reporting in Financial Services Modernizing CRA Regulations Managing compliance risk frameworks in alignment with existing risk profiles is crucial as customer needs evolve. The effective date of the new rule is April 1, 2024, with key provisions taking effect on January 1, 2026, and January 1, 2027. Banks

Compliance 52

Compliance Regulations Production 52

Alta Sciences

JULY 10, 2024

Inside The Altascientist: Nonclinical Dermal Study Considerations pmjackson Wed, 07/10/2024 - 15:25 An increasing number of advanced methods for dermal drug delivery contribute to successful 505(b)(2) applications and extend the patent life of a drug for its sponsor.

Clinical Trials 52

Clinical Trials Compliance Trials Drug Development 52

Alta Sciences

AUGUST 7, 2024

blussier Wed, 08/07/2024 - 19:51 HTML Timing is Everything Early collaboration with an experienced CDMO is crucial in drug development to mitigate manufacturing risks and ensure the efficient formulation of your API for preclinical and clinical testing. Contact us today to discuss the next stage of your drug development journey.

Clinical Trials 40

Clinical Trials Compliance Drug Development Trials 40

Perficient: Drug Development

NOVEMBER 21, 2024

The first compliance deadline of April 1, 2026, impacts the largest organizations. The compliance deadline, however, depends on the firm’s total receipts from calendar years 2023 and 2024. The compliance deadline, however, depends on the firm’s total receipts from calendar years 2023 and 2024.

Compliance 52

Compliance Engineering Regulations Production 52

Perficient: Drug Development

MARCH 5, 2024

In the fast-paced digital landscape of 2024, businesses are constantly seeking innovative solutions to enhance efficiency, security, and transparency in their operations. Identity Verification: In industries such as finance, healthcare, and government, identity verification is paramount for security and compliance purposes.

Compliance 59

Compliance Production Government 59

Perficient: Drug Development

OCTOBER 15, 2024

In the banking sector, data governance is more than just a compliance checkbox. Thankfully, in 2024, we’re spoiled with a variety of platforms designed specifically to handle this madness. Financial services companies like AXA and ABN AMRO rely on these tools to handle everything from compliance workflows to data lineage mapping.

Government 52

Government Compliance Regulations Production 52

Agency IQ

FEBRUARY 2, 2024

Diagnostics landscape analysis: Key issues and a look ahead at 2024 Diagnostic regulation in the U.S. Following significant policy proposals in recent years, 2024 is gearing up to be a profoundly impactful year for diagnostics developers and the policymakers who regulate them. is a constantly evolving topic. That depends.

FDA 40

FDA Laboratories Regulations Production 40

Perficient: Drug Development

DECEMBER 27, 2024

Regulatory Compliance: Ensure compliance with regulatory requirements through automated monitoring and reporting. This assessment covers data quality, compliance, security, and language learning models (LLMs). Financial Services Risk Management: Use AI to detect fraud and manage risks more effectively. and Perficient.

Compliance 52

Compliance Production Treatment Marketing 52

Perficient: Drug Development

DECEMBER 21, 2023

Regulators to Bank Boards: “Debt is Good” Crucial Update: Extension of the Comment Period Since Perficient’s Risk and Regulatory Compliance Center of Excellence (CoE) analyzed this decision in September, a significant development has occurred. Learn More: U.S.

Compliance 52

Compliance Regulations Research 52

Perficient: Drug Development

NOVEMBER 15, 2024

And this year is especially interesting, as 2024’s U.S. These regulations demand that healthcare AI be specifically tailored to ensure data privacy, security, and compliance, limiting the utility of plug-and-play approaches seen in other industries. Upcoming mandates are meant to build upon those that came before.

Regulations 64

Regulations Compliance Production Nurses 64

Alta Sciences

MARCH 8, 2024

Inside the Altascientist: Considerations for Safe and Compliant HPAPI Manufacturing pmjackson Fri, 03/08/2024 - 19:35 In recent years, advancements in oncological research have fueled a surge in demand for highly potent active pharmaceutical ingredients ( HPAPIs ). So much so that the HPAPI market is estimated to reach USD 31.5

Compliance 52

Compliance Engineering Regulations Drug Development 52

Perficient: Drug Development

JANUARY 3, 2024

Additionally, these branches underwent annual on-site inspections to ensure compliance with regulations. Without action, this temporary relief would have expired on June 30, 2024, and would have significantly impacted the industry due to an estimated 75% increase in residential non-branch locations between December 2019 and December 2022.

Compliance 52

Compliance Regulations 52

Perficient: Drug Development

NOVEMBER 15, 2024

And this year is especially interesting, as 2024’s U.S. These regulations demand that healthcare AI be specifically tailored to ensure data privacy, security, and compliance, limiting the utility of plug-and-play approaches seen in other industries. Upcoming mandates are meant to build upon those that came before.

Regulations 52

Regulations Compliance Production Nurses 52

Drug Target Review

DECEMBER 5, 2024

As a result, there is a need for validated AAV testing solutions to meet quality standards as well as compliance and regulatory requirements. Access to fast, high-throughput tools during the manufacturing process will accelerate the development of therapeutics while adhering to regulations and stringent quality standards. Labcompare.

Therapies 52

Therapies Virus DNA Compliance 52

Advarra

APRIL 4, 2024

Setting up a DSMB involves identifying qualified experts, negotiating contracts, and ensuring compliance with regulatory requirements for each board. As the board becomes familiar with the company’s protocols and reporting mechanisms, discussions can be more focused, potentially accelerating the pace of clinical development.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Trials Trials FDA 52

Vial

MAY 20, 2024

Clinical CROs in Clinical Research Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of the long, arduous drug development pipeline. The two broadest categories of drug development can be separated into the preclinical and clinical research stages. over this period.

Clinical Research 52

Clinical Research Clinical Trials Research Trials 52

Perficient: Drug Development

SEPTEMBER 11, 2024

Here’s everything you need to know about Sitecore Symposium 2024 and what to expect from team Perficient. Perficient’s Presence at Symposium 2024 Perficient is thrilled to be a sponsor at Sitecore Symposium 2024. What is Sitecore Symposium? Sitecore Symposium is Sitecore’s biggest event of the year.

Compliance 52

Compliance Engineering Production Marketing 52

Perficient: Drug Development

JANUARY 24, 2024

Before I begin, I just want to caveat everything with the fact that HIPAA is a complex regulation open to interpretation, and in the end your legal and compliance teams need to be comfortable with how you handle data and the risk associated with those methods.

Licensing 96

Licensing Licensing Production Regulations 96